Patents
Sitemap › C12 - Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation or genetic engineering › C12N - Micro-organisms or enzymes; Compositions thereof; Propagating, preserving, or maintaining micro-organisms; Mutation or genetic engineering; Culture media › C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629)
09/2003
09/12/2003WO2003073998A2 Local production and/or delivery of anti-cancer agents by stromal cell precursors
09/12/2003WO2003073996A2 Human schwannoma cell line
09/12/2003WO2003073982A2 Anti-interleukin-1 beta analogs
09/12/2003WO2003073980A2 Recombinant protein c variants
09/12/2003WO2003073916A2 Immune regulation
09/12/2003WO2003073912A2 Pre-fabricated tissue-engineered plug
09/12/2003WO2003073843A2 Inbred embryonic stem-cell derived mice
09/12/2003WO2003073841A2 Transgenic non-human mammals expressing constitutively activated tyrosine kinase receptors
09/12/2003WO2003073827A2 Methods of modulating dendritic cells using adjuvants
09/12/2003WO2003073821A2 Shc PROTEIN-RELATED METHODS AND COMPOSITIONS FOR THE PROGNOSIS OF BREAST, PROSTATE AND OVARIAN CANCER
09/12/2003WO2003065973A8 Multivalent streptococcal vaccine compositions and methods for use
09/12/2003WO2003048364A3 Ovomucoid promoter and methods of use
09/12/2003WO2003046133A3 Regulatory nucleic acid assay for diagnostic and library screens
09/12/2003WO2003035884A3 Transient immortalization
09/12/2003WO2003032814A3 Antibodies that bind to cancer-associated antigen cd46 and methods of use thereof
09/12/2003WO2003031579A3 Human tyrosine-dna phosphodiesterase variant polypeptides and methods of use therefor
09/12/2003WO2003029446A3 Methods for producing in-vitro hollow organs
09/12/2003WO2003026401A3 Kv3.3b POTASSIUM CHANNEL DISRUPTIONS, COMPOSITIONS AND METHODS RELATED THERETO
09/12/2003WO2003011893A3 Immunologically significant herpes simplex virus antigens and methods for using same
09/12/2003WO2003006612A3 Production of transduced hematopoietic progenitor cells
09/12/2003WO2002097128A3 Method for identifying substances directed against myocardial cell hypertrophy
09/12/2003WO2002086073A3 Generation of differentiated tissue from nuclear transfer embryonic stem cells and methods of use
09/12/2003WO2002082041A3 Production and use of novel peptide-based agents for use with bi-specific antibodies
09/12/2003WO2002075507A3 Anti-bacterial vaccine compositions
09/12/2003WO2002072830A3 Proteins associated with cell growth, differentiation, and death
09/12/2003WO2002062205A3 Methods for diagnosing and treating heart disease
09/12/2003WO2002059263A9 Transgenic animals comprising a humanized immune system
09/12/2003WO2002048370A3 Compositions and methods relating to colon specific genes and proteins
09/12/2003WO2002042461A3 Endogenous and non-endogenous versions of human g protein-coupled receptors
09/12/2003WO2002032961A8 Novel polypeptides and nucleic acids encoding same
09/12/2003WO2002029015A9 Assay for rapid detection of human activated protein c and highly specific monoclonal antibody therefor
09/12/2003WO2002028424A9 Kyberdrug as autovaccines with immune-regulating effects
09/12/2003WO2002018572A3 Membrane penetrating peptides and uses thereof
09/12/2003WO2002010355A3 Alpha-amylase mutants with altered stability
09/12/2003CA2478649A1 Means and methods for manipulating hypersensitivity-like responses
09/12/2003CA2478636A1 Spheron components useful in determining compounds capable of treating symptoms of alzheimer's disease, and treatments and animal models produced therefrom
09/12/2003CA2477969A1 Falp proteins
09/12/2003CA2477953A1 Shc protein-related methods and compositions for the prognosis of breast, prostate and ovarian cancer
09/12/2003CA2477940A1 Methods of constructing a model of cellular development and differentiation using homozygous stem cell systems, methods of assessing and cataloging proteins expressed therein, cdna libraries generated therefrom, and materials and methods using same
09/12/2003CA2477876A1 Recombinant protein c variants
09/12/2003CA2477874A1 Expression cassette for persistence of expression of a gene of interest in muscle cells
09/12/2003CA2477849A1 Method for producing riboflavin
09/12/2003CA2477762A1 Peptides for use in antitumor immunotherapy
09/12/2003CA2477662A1 Genes involved in regulating angiogenesis, pharmaceutical preparations containing same and applications thereof
09/12/2003CA2477442A1 Lis promoter for expression of transgenes in floral tissues
09/12/2003CA2477411A1 Local production and/or delivery of anti-cancer agents by stromal cell precursors
09/11/2003US20030172408 Transcription factor stress-related polypeptides and methods of use in plants
09/11/2003US20030172400 Comprises nucleotide sequences coding anthocyanidin-rutinoside acyltransferase (AR-AT) for improving/increaseing flower varieties; horticulture
09/11/2003US20030172399 Nucleic acid sequences and methods of use for the production of plants with modified polyunsaturated fatty acids
09/11/2003US20030172397 Papaya ringspot virus genes
09/11/2003US20030172391 A transgenic mouse; the enzyme for treating inflammation, smooth muscle contraction; animal models
09/11/2003US20030172390 Mo54 gene disruptions, compositions and methods related thereto
09/11/2003US20030171567 Recombinant allergen, fragments thereof, corresponding recombinant DNA molecules, vectors and hosts containing the DNA molecules, diagnostic and therapeutic uses of said allergens and fragments
09/11/2003US20030171566 An isolated human nucleic acid encoding a nevoid basal cell carcinoma syndrome protein, antibodies, detecting tumor protein, therapeutic treatment of tumor, cancer; genetic engineering
09/11/2003US20030171564 Novel argS
09/11/2003US20030171556 Diagnosis and therapeutic treatment of Alzheimer's Disease; drug screening
09/11/2003US20030171550 Secreted and transmembrane polypeptides and nucleic acids encoding the same
09/11/2003US20030171546 Chimeric immunoreceptor useful in treating human cancers
09/11/2003US20030171541 Selective binding agents, vectors, host cells, and methods for producing GPCR polypeptides; diagnosis, treatment, amelioration, and/or prevention of diseases, disorders, and conditions associated with GPCR polypeptides
09/11/2003US20030171435 New amphetamine derivatives, antibodies against them and pharmaceutical compositions containing them
09/11/2003US20030171336 A packaging cell line capable of complementing recombinant adenoviruses based on serotypes from subgroup B, preferably adenovirus type 35. The cell line is preferably derived from primary, diploid human cells transformed by adenovirus E1
09/11/2003US20030171334 Treatment of prostate cancer
09/11/2003US20030171324 Reagents which bind to human DESC1-like serine protease gene products can play a role in preventing, ameliorating, or correcting dysfunctions or diseases including, but not limited to cancer, chronic obstructive pulmonary disease (COPD),
09/11/2003US20030171320 Methods for treating ocular neovascular diseases
09/11/2003US20030171319 Human chemokine beta-10 mutant polypeptides
09/11/2003US20030171318 Methods for inhibiting virus propagation and treating virus infection are provided which include administering to cells infected with viruses a compound capable of inhibiting viral budding from the cells.
09/11/2003US20030171290 Methods to determine peptides presented on the surface of mammalian cells following addition to the cells of a protein. The present invention also relates to diagnostic tests based on the determination of such peptides or modified molecules
09/11/2003US20030171289 Peptides blocking vascular endothelial growth factor (VEGF)-mediated angiogenesis, polynucleotides encoding said peptides and methods of use thereof
09/11/2003US20030171279 Methods and composition concerning herpesvirus Us3 and BAD-involved apoptosis
09/11/2003US20030171278 Novel compounds which bind to the human erbB2 gene product (ErbB2, also known as HER2, or c-ErbB-2). In particular aspects, the invention provides for the treatment of disorders characterized by the overexpression of ErbB2 utilizing the
09/11/2003US20030171273 DNA of SEQ ID NO:1 is provided that encodes the transcription factor BP1, which is believed to be a repressor of the beta -globin gene. A host cell that is transformed with a vector that contains the DNA may be used to produce BP1.
09/11/2003US20030171267 Albumin fusion proteins
09/11/2003US20030171252 Nucleic acid molecules are provided encoding novel polypeptides. Novel polypeptides and antibodies that bind to these polypeptides are provided. Also provided are vectors, host cells, and recombinant and synthetic methods for human
09/11/2003US20030170896 Adeno-asociated virus (AAV) vectors that are capable of being transferred between cells; used to support comercially significant levels or rAAV particles without infectious helper virus or other harmful by-products
09/11/2003US20030170895 Methods of making hypermutable cells using PMSR homologs
09/11/2003US20030170892 For therapeutic treatment of skin wounds,testing of skin anatomy or physiology
09/11/2003US20030170890 Produced by conversion of healthy myocardial cell by stimulation with hormones, hormone analogs and/or cytokines; used for detecting and identifying substances acting on the heart
09/11/2003US20030170889 In vivo assay for anti angiogenic compounds
09/11/2003US20030170887 Insect cell primary culture meduim, extra cellular matrix, and process of preparing an insect culture cell line in a short period of time using the medium and matrix
09/11/2003US20030170885 Used for the transfer and expression of exogenous nucleotide sequences in a host cell or organism; gene therapy
09/11/2003US20030170864 Secreted and transmembrane polypeptides and nucleic acids encoding the same
09/11/2003US20030170863 Prevents side effects such as systemic activation of coagulation system, bleeding
09/11/2003US20030170860 Polynucleotide encoding a polypeptide having heparanase activity and expression of same in genetically modified cells
09/11/2003US20030170859 Gene expression inhibition; for treatment of inflammatory, neurological, cardiovascular, and neoplastic tisssue growth disorders
09/11/2003US20030170854 Recombinant human creatine kinase heterodimer with solution-stability
09/11/2003US20030170847 Genes involved in isoprenoid compound production
09/11/2003US20030170842 Crystal proteins comprising proline substitutions; vapor diffusion; nuclear magnetic resonance; high resolution
09/11/2003US20030170840 Genomic mammary amyloid a sequence
09/11/2003US20030170839 Type 2 cytokine receptor and nucleic acids encoding same
09/11/2003US20030170838 Novel polynucleotides and polypeptides encoded thereby
09/11/2003US20030170833 Prenyltransferases; soybean proteins; improving plant growth
09/11/2003US20030170825 Comprises antihemophilic factor (factor VIII) and antitrypsin signal sequences; for treatment of hemophilia
09/11/2003US20030170816 Method for in vitro propagation of the agent responsible for transmissible spongiform encephalopathies
09/11/2003US20030170809 Of given amino acid sequence; use in stimulating cell proliferation and differentiation and in diagnosing tumors
09/11/2003US20030170808 Polypeptide encoded by polynucleotide of given sequence; use in diagnosis and treatment of various diseases
09/11/2003US20030170804 Isolated nucleic acid encoding a polypeptide that blocks differentiation of stem cells
09/11/2003US20030170792 MAGE-3 peptides presented by HLA class ll molecules
09/11/2003US20030170790 Of given amino acid sequence; use in modulating cell activity, stimulating release of tumor necrosis factor, proteoglycans and cytokines; detecting tumors
09/11/2003US20030170789 Of given amino acid sequence; use in modulating cell activity, stimulating release of tumor necrosis factor, proteoglycans and cytokines; detecting tumors
09/11/2003US20030170788 Secreted and transmembrane polypeptides and nucleic acids encoding the same
1 ... 1169 1170 1171 1172 1173 1174 1175 1176 1177 1178 1179 1180 1181 1182 1183 1184 1185 1186 1187 1188 1189 ... 1827